Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2002
10/31/2002WO2001093897A3 Angiostatin and endostatin binding proteins and methods of use
10/31/2002WO2001075067A9 Novel nucleic acids and polypeptides
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002WO2001064898A3 Genes encoding denitrification enzymes
10/31/2002WO2001060985A9 Compositions, methods and kits relating to uridine phosphorylase gene mutations
10/31/2002WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002WO2001059081A9 Methods for using 20893, a human protein kinase
10/31/2002WO2001055432A3 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/31/2002WO2001053793A9 A novel steroid hormone receptor interacting protein kinase
10/31/2002WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002US20020162140 Expression of recombinant human acetylcholinesterase in transgenic plants
10/31/2002US20020162138 Transgenic plants and plant cells, in which an amylopectin with an altered degree of branching is synthesized
10/31/2002US20020162137 Materials and methods for the alteration of enzyme and acetyl coa levels in plants
10/31/2002US20020162136 For preventing and/or reducing fungal growth on a plant, plant tissue, seed or plant cell
10/31/2002US20020162130 Transgenic mouse expressing the human cyclooxygenase-2 gene and neuronal cell cultures derived therefrom
10/31/2002US20020162127 For use in diagnostic, therapeutic, and investigational procedures
10/31/2002US20020161599 Electronic database of enzyme substrate and enzyme inhibitor structures
10/31/2002US20020161214 Novel human proteases and polynucleotides encoding the same
10/31/2002US20020161213 Novel human kinases and polynucleotides encoding the same
10/31/2002US20020161208 Useful for diagnosing, therapy, prophylaxis and/or prognosing disorders related to these novel polypeptides
10/31/2002US20020161192 Helicobacter pylori live vaccine
10/31/2002US20020160980 Method of treating hepatitis delta virus infection
10/31/2002US20020160978 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
10/31/2002US20020160977 Method for selective inactivation of viral replication
10/31/2002US20020160976 Method for selective inactivation of viral replication
10/31/2002US20020160975 IAPX, member of the Inhibitor of Apoptosis Protein (IAP) family; Smac/DIABLO, a mitochondrial protein; polypeptide that binds to IAP
10/31/2002US20020160972 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
10/31/2002US20020160969 Nucleosides and oligonucleotides containing boron clusters
10/31/2002US20020160962 Non-structural protein 3 (NS3), part of a hepatitis C virus protease necessary for polypeptide processing and viral replication; alpha-ketoamide compounds of given formula
10/31/2002US20020160950 Cytochrome P450 variant
10/31/2002US20020160940 Modulation of endogenous gene expression in cells
10/31/2002US20020160933 Methods and compositions for producing a neurosalutary effect in a subject
10/31/2002US20020160927 Enzyme containing granule
10/31/2002US20020160915 Altering the ATP gradient across the membrane of a target cell by inhibiting an extracellular phosphatase (ecto-phosphatase) in the target cell
10/31/2002US20020160500 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203
10/31/2002US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002US20020160492 Bovine aggrecanase-1
10/31/2002US20020160490 For screening physiologically active substances using serine protease or DNA that codes for it
10/31/2002US20020160489 Used in preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product
10/31/2002US20020160486 Human RNase H1 mutants
10/31/2002US20020160485 Polynucleotide motor, a motor system, their preparation and uses
10/31/2002US20020160484 Central nervous system disorders therapy; genetic engineering
10/31/2002US20020160483 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
10/31/2002US20020160482 Genetic engineering; fusion proteins; transfection, culture product; immobilization
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160480 Erythrose reductase, its cDNA and cell which the cDNA express
10/31/2002US20020160479 Identification of a new member of the cytochrome P450 3A (CYP3A): gene family: CYP3AX
10/31/2002US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002US20020160468 Using nicotinamide-adenine dinucleotide coenzyme
10/31/2002US20020160466 Form nitrile in aqueous solution
10/31/2002US20020160464 Enzymes having alpha-galactosidase activity and methods of use thereof
10/31/2002US20020160461 Method for producing substance utilizing microorganism
10/31/2002US20020160460 Practical in vitro sialylation of recombinant glycoproteins
10/31/2002US20020160459 Process for production of n-glucosamine
10/31/2002US20020160458 Gene expression of endoprotease in eukaryotic cells; yeast culture product
10/31/2002US20020160452 25206, a novel human short-chain dehydrogenase/reductase family member and uses thereof
10/31/2002US20020160447 Ups (ugc)
10/31/2002US20020160445 Side effect reduction
10/31/2002US20020160433 Diagnosis of urogenital disorders
10/31/2002US20020160399 Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
10/31/2002US20020160397 Measuring variations; calibration
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002US20020160384 Polypeptides; binding to antibodies
10/31/2002US20020160380 Combinatorial libraries by recombination in yeast and analysis method
10/31/2002US20020160374 Fusion protein; genetic engineering; binding to antibodies
10/31/2002US20020160365 Compositions and methods for the early diagnosis of ovarian cancer
10/31/2002US20020160080 Animal feed additives
10/31/2002US20020160006 Methods of treating lymphoma and leukemia
10/31/2002US20020159992 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
10/31/2002US20020159991 Modulation of Abeta levels by beta-secretase BACE2
10/31/2002US20020159990 Synergistic degradation of oligosaccharides by endoglucanases, resulting in the production of ethanol from complex cellulose substrates
10/31/2002US20020159989 Peptide that interacts with thrombospondin 2 and inhibits matrix metalloproteinase 9 (MMP-9) activity, useful for treating diseases, such as cancer and arthritis
10/31/2002US20020159988 Lytic enzyme produced by bacteria being infected with a bacteriophage specific for such bacteria, useful for treating eye infection
10/31/2002US20020159987 Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
10/31/2002US20020159978 RAAV virion(recominant adeno-associated virus) comprising an AAV-6 capsid, and a heterologous nucleic acid encoding Factor IX operably linked to expression control element, administering virion to a muscle cell
10/31/2002US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering
10/31/2002EP0760670A4 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis
10/31/2002DE10119274A1 Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen Enzymatic method for the enantioselective reduction of keto compounds
10/31/2002DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445354A1 Nucleic acid molecules encoding starch degrading enzymes
10/31/2002CA2445168A1 Human timp-1 antibodies
10/31/2002CA2445011A1 Transformed silkworm producing human collagen
10/31/2002CA2444967A1 Biological sample processing methods and compositions that include surfactants
10/31/2002CA2444209A1 Active site inactivators
10/31/2002CA2444098A1 Methods and compositions for the production of orthogonal trna-aminoacyl trna synthetase pairs
10/31/2002CA2443757A1 In vivo incorporation of unnatural amino acids
10/31/2002CA2443710A1 Biological sample processing methods and compositions that include surfactants
10/31/2002CA2441783A1 Genes involved in isoprenoid compound production
10/31/2002CA2438539A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/30/2002EP1253475A2 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner
10/30/2002EP1253202A1 Expression cassette comprising the Arabidopsis thaliana trehalose-6-phosphate synthase 3 (TPS3) promoter for strong constitutive gene expression
10/30/2002EP1253199A1 Abasic moieties containing enzymatic nucleic acids
10/30/2002EP1253198A1 Plant adpglucose pyrophosphatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants
10/30/2002EP1252897A1 Drugs for gene therapy
10/30/2002EP1252879A1 Stabilised enzyme compositions
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252318A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid
10/30/2002EP1252317A2 Human enzymes and polynucleotides encoding the same
1 ... 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 ... 1416